Target Audience

This program has been designed by a multidisciplinary faculty and the content is pertinent to the entire cancer team, including hematologists/oncologists, community oncologists, nurses, physician assistants and researchers.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Summarize the role of the immune system in tumor biology and how current immunotherapeutic approaches exploit these processes.
  • Assess the latest clinical advances regarding the use of immunotherapies and targeted therapies in various solid tumors and hematologic malignancies.
  • Determine how immunotherapy and targeted therapy fit into existing treatment pathway paradigms in various solid tumors and hematologic malignancies.
  • Examine paradigms for the use of immunotherapies with each other or alternative treatment modalities for cancer management.
  • Review strategies for the recognition and management of immune-mediated adverse events.
  • Describe emerging challenges associated with the use of immunotherapies and targeted therapies for cancer management.
This continuing medical education activity is provided by

HemOnc Today New York 2018 is supported, in part, by independent educational grants from AstraZeneca; Bristol-Myers Squibb; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Prometheus Laboratories Inc.

ACCREDITATION: Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for a maximum of 21 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.